top of page

Diabetes Prevention and Treatment Workshop


The world’s largest diabetic epidemic is in China, where more than 110 million people have been
diagnosed with diabetes. China faces the daunting task of treating and managing the disease in a
fragmented health care delivery system that is stifled by an elementary primary care system, uneven distribution of healthcare resources, and multiple challenging social factors such as poverty, work stress, and unhealthy diet and lifestyle. Frontline healthcare providers need a more integrated and coordinated health system that strengthens primary care, fosters close collaboration between hospitals and the local community, and focuses on proactive health and preventative medicine for better disease management and patient behavior change rather than reactive medicine.

The Diabetes Prevention and Treatment Workshop provides participants with the insiders’ perspective of diabetes management experience from top U.S. health care providers, public health and policy researchers from Harvard Medical School and affiliated hospitals. The program introduces some of the advanced treatment and care models as well as innovative approaches that have been proven to be successful in managing diabetes and related chronic diseases. Participants are expected to learn how U.S. insurance companies, health care providers, startups and communities work together to increased quality of care while controlling costs. Application of innovations and cutting-edge advances in science and technology in chronic disease management will also be covered in this program.



Who Should Attend

The program is designated for Chinese endocrinology directors and chief physicians who are at the front line of China’s diabetes treatment. Policy makers and innovators who want to make an impact on chronic disease care are also encouraged to attend.



Key Benefits

This program prepares participants to become the leaders in chronic disease management with a deep dive on the following topics:

  • Update in Diabetes Treatment and Complication Management in the United States

  • Diabetes Care for special subgroups including Asian, the young and aging population and pregnant women

  • Progress in diabetes research and scientific research in the U.S.

  • The role of new policy, insurance, technology, and care models in managing diabetes in 

  • Good examples of care coordination in hospitals and community settings



Registration Policy



Please contact for enquiries and registrations.


Invitation Letter

The invitation letter will be provided after we receive full payments. Please note that we cannot contact the U.S. Embassy or General Consulate on behalf of our participants, and we are not in a position to influence visa application processes.



We only accept cancellation notices in writing. Cancellations before 8 March 2019 will be refunded with an administrative fee of $50. Cancellations after 8 March 2019 are not refundable.


Attendee Replacement

Attendee replacement requests submitted prior 8 March 2019 will be accepted for free. An administrative fee of $150 will be incurred after this date.




Program Information

Program Dates

April 23-26, 2019

Training Fees

Enquire Us

Teaching Format


All classes take place at the Harvard Medical School Department of Population Medicine / Harvard Pilgrim Health Care Institute.

Learning formats include lectures, case studies, in-class discussions, and visits to Harvard-affiliated teaching hospitals.

Teaching Faculty

This program is taught by world-renowned faculties and clinical experts within Harvard Medical School and affiliated teaching hospitals, including the following: 


Clinical Treatment and Management

  • David Nathan, MD, Director, Diabetes Center, Massachusetts General Hospital; Professor, Harvard Medical School

  • Joe Kimura, MD, Chief Medical Officer, Atrius Health

  • William Hsu, MD, Director of Asian American Diabetes Initiative, Joslin Diabetes Center

  • Robert Janett, MD, Assistant Professor of Medicine, Cambridge Health Alliance (CHA)

  • Marie-France Hivert, MD, MSc, Associate Professor, Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute


Research and Innovation

  • George King, MD, Chief Scientific Officer, Joslin Diabetes Center; Professor, Harvard Medical School

  • David Mou, MD, MBA, Co-founder and Medical Director, Valera Health, Psychiatrist, Massachusetts General Hospital

  • Michael Klompas, MD, MPH, Professor, Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute

  • Richard Platt, MD, Professor and Chair, Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute


Policy and Management

  • Leonard Marcus, PhD, Founding Director, Program for Health Care Negotiation and Conflict Resolution, Harvard T.H. Chan School of Public Health

  • Dennis Ross-Degnan, ScD, MSPH, Associate Professor, Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute


*Due to lecturers’ uncertain schedules, this list may have slight changes.

bottom of page